Who Owns Alkermes Stock?
NASDAQ: ALKSHealthcareDrug Manufacturers - Specialty & GenericUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 107.47%
- Institutions (% of float)
- 109.00%
- Held by insiders
- 1.40%
- Institutional holders
- 570
- Institutions 98.6%
- Insiders 1.4%
- Public and other 0.0%
Who owns Alkermes stock?
Institutional investors own about 107.5% of Alkermes's shares, spread across 570 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 1.40% of ALKS.
The largest institutional holders are Blackrock Inc. (17.43%), Baker Bros. Advisors, LP (5.97%) and Vanguard Portfolio Management LLC (5.66%). Together, the top 10 institutions control 54.4% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their ALKS positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ALKS
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 29.24M | 17.43% | +3.3% |
| Baker Bros. Advisors, LP | 10.01M | 5.97% | 0.0% |
| Vanguard Portfolio Management LLC | 9.49M | 5.66% | -0.2% |
| State Street Corporation | 9.16M | 5.46% | -3.2% |
| Vanguard Capital Management LLC | 7.52M | 4.48% | +1.2% |
| Price (T.Rowe) Associates Inc | 6.74M | 4.02% | +44.4% |
| Renaissance Technologies, LLC | 6.46M | 3.85% | +4.9% |
| Geode Capital Management, LLC | 4.48M | 2.67% | +7.1% |
| Dimensional Fund Advisors LP | 4.19M | 2.50% | -7.2% |
| Deep Track Capital, Lp | 4.00M | 2.38% | +11.4% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ALKS
| Fund | Shares | % Held |
|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 10.16M | 6.06% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 5.30M | 3.16% |
| iShares Trust-iShares Russell 2000 ETF | 4.27M | 2.55% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 3.82M | 2.28% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.39M | 1.43% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 2.20M | 1.31% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.91M | 1.14% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.83M | 1.09% |
| First TRT Exch-Trd Fd.-First TRT NYSE Arca Biotechnology Index Fd. | 1.74M | 1.04% |
| VANGUARD HORIZON FUNDS-Vanguard Capital Opportunity Fund | 1.72M | 1.02% |
Frequently asked questions
Who is the largest shareholder of Alkermes?
Blackrock Inc. is the largest institutional shareholder of ALKS, owning 17.43% of shares outstanding (29.24M shares) as of its latest 13F filing.
What percentage of Alkermes is owned by institutions?
Institutions own about 107.5% of ALKS shares and 109.0% of the public float.
How much of Alkermes do insiders own?
Insiders, such as officers and directors, own about 1.40% of ALKS shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.